DEFERASIROX Spirig HC cpr pell 900 mg 90 pce

7680688710083 CH-68871 V03AC03 06.99.0.

Reimbursement limitations:

JADENU

Un remboursement est effectué
 - en tant que traitement de première intention pour le traitement …

DEFERASIROX Spirig HC cpr pell 900 mg 90 pce
DEFERASIROX Spirig HC cpr pell 900 mg 90 pce
DEFERASIROX Spirig HC cpr pell 900 mg 90 pce
1 / 3
google

Details

Product number
6887104
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
deferasiroxum 900 mg, cellulosum microcristallinum, crospovidonum, povidonum K 30, poloxamerum 188, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, macrogolum 4000, talcum, E 171 pro compresso obducto.

Articles (1)

Deferasirox Spirig HC 900 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/12/2024
Patient information leaflet
Français
04/12/2024
Patient information leaflet
Italien
04/12/2024
Professional SmPC
Allemand
04/12/2024
Professional SmPC
Français
04/12/2024
Professional SmPC
Italien
04/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
900.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 2209.20
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2025

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68871
Drug name
Deferasirox Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
V03AC03
Authorization status
Z
Dispensation category
B
First authorization
17/02/2023
Authorization expiration date
16/02/2028
IT number
06.99.0.
Domain
Human medicine
Field of application
Behandlung der transfusionsbedingten Hämosiderose. Behandlung von chronischer Eisenüberladung, die eine Chelattherapie erfordert, bei Patienten mit nicht-transfusionsabhängiger Thalassämie ab 10 Jahren.

Packaging details

Description (FR)
DEFERASIROX Spirig HC cpr pell 900 mg 90 pce
Description (DE)
DEFERASIROX Spirig HC Filmtabl 900 mg 90 Stk
Market launch
16/08/2024
Narcotic (BTM)
No

Original drug

Jadenu, Filmtabletten
CHF 221.40
View original

Other packaging sizes

DEFERASIROX Spirig HC cpr pell 90 mg 30 pce
30 TABL
View
DEFERASIROX Spirig HC cpr pell 90 mg 90 pce
90 TABL
View
DEFERASIROX Spirig HC cpr pell 180 mg 30 pce
30 TABL
View
DEFERASIROX Spirig HC cpr pell 180 mg 90 pce
90 TABL
View
DEFERASIROX Spirig HC cpr pell 360 mg 30 pce
30 TABL
View
DEFERASIROX Spirig HC cpr pell 360 mg 90 pce
90 TABL
View
DEFERASIROX Spirig HC cpr pell 900 mg 30 pce
30 TABL
View